Home/Filings/4/0001209191-19-037992
4//SEC Filing

Hendrick Edwin 4

Accession 0001209191-19-037992

CIK 0001044378other

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 4:13 PM ET

Size

5.7 KB

Accession

0001209191-19-037992

Insider Transaction Report

Form 4
Period: 2019-04-30
Hendrick Edwin
SVP, Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-04-30+160,000160,000 total
    Exercise: $0.91Exp: 2029-04-29Common Stock (160,000 underlying)
Footnotes (1)
  • [F1]The option was granted on 4/30/19, but was contingent on shareholder approval of an increase in the shares issuable under the Issuer's 2013 Amended and Restated Equity Incentive Plan at the Issuer's annual meeting of stockholders held on 6/17/19, and therefore for purposes of Section 16 the option was not "acquired" until such stockholder approval was obtained. 25% of the shares subject to the option shall vest on the first annual anniversary of the Vesting Commencement Date (4/30/19) with the balance vesting in equal monthly installments thereafter until fully vested on 4/30/23.

Issuer

BIOCEPT INC

CIK 0001044378

Entity typeother

Related Parties

1
  • filerCIK 0001380536

Filing Metadata

Form type
4
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 4:13 PM ET
Size
5.7 KB